| Nov 15 |
Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 13 |
Predictive Oncology GAAP EPS of -$0.36 misses by $0.10, revenue of $0.35M in-line
|
| Nov 13 |
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
|
| Oct 9 |
Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ...
|
| Sep 5 |
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 27 |
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
|
| Aug 20 |
Predictive Oncology Inc. (NASDAQ:POAI) Is Expected To Breakeven In The Near Future
|
| Aug 15 |
Predictive Oncology files to sell 1.98M shares of common stock for holders
|
| Aug 14 |
Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
Predictive Oncology GAAP EPS of -$0.68, revenue of $0.28M
|
